Showing Form 4 filings for ABCL
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Abcellera Biologics Inc.
Price
$11.33
Shares
8,600
Ownership
622,359
Value/Share
Booth Andrew
CFO
Unknown
Industry
$10.50
147,200
2,361,401
Multiple Insiders
3 Insiders
Pharmaceutical Preparations